oxybutynin has been researched along with buprenorphine in 53 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 44 (83.02) | 24.3611 |
| 2020's | 9 (16.98) | 2.80 |
| Authors | Studies |
|---|---|
| Andresen, T; Arendt-Nielsen, L; Christrup, LL; Drewes, AM; Foster, DJ; Upton, RN | 1 |
| Hale, M; Landau, C; Munera, C; Ripa, S; Steiner, D | 1 |
| Dobrogowski, J; Przeklasa-Muszyńska, A | 1 |
| Plosker, GL | 1 |
| Lyseng-Williamson, KA; Plosker, GL | 1 |
| Landau, CJ; McCarberg, BH; Munera, C; Ripa, SR; Wen, W | 1 |
| Aune, D; Hernandez, AV; Kleijnen, J; Misso, K; Riemsma, R; Truyers, C; Wolff, RF | 1 |
| Al-Tawil, N; Berggren, AC; Johnson, HE; Odar-Cederlöf, I; Persson, J | 1 |
| Fontenelle, DV; Fudin, J; Payne, A | 1 |
| Chowdhury, S; Mitra, F; Shelley, M; Williams, G | 1 |
| Brennan, MJ; Dain, B; Lynch, SY; Miller, K; Ripa, SR; Wen, W; Yarlas, A | 1 |
| Lane, ME | 1 |
| Lynch, SY; Maibach, H; Munera, C; Ripa, SR; Swanton, R; Wen, W | 1 |
| Andresen, T; Arendt-Nielsen, T; Drewes, AM; Gram, M; Graversen, C; Mørch, CD; Nielsen, AK | 1 |
| Cannata, F; Canneti, A; Di Marco, P; Luzi, M; Pasqualitto, F; Reale, C; Spinoglio, A | 1 |
| Aarsland, D; Ballard, C; Cohen-Mansfield, J; Husebo, BS; Seifert, R | 1 |
| Björholt, I; Ericson, L; Lesén, E; Simonsberg, C; Söderpalm, B; Varelius, R | 1 |
| Hamaguchi, S; Ikeda, T | 1 |
| Ito, G; Kanemoto, K | 1 |
| Calderon, R; Copenhaver, D | 1 |
| Augustini, BG; Berggren, AC; Karlsson, J; Söderström, A | 1 |
| Ben-Joseph, R; Chang, CL; Hess, G; Pergolizzi, JV | 2 |
| Aarsland, D; Ballard, C; Corbett, A; Husebo, BS; Sandvik, RK; Seifert, R; Selbaek, G | 1 |
| Hägg, S; Holmlund, M; Lövborg, H | 1 |
| Müller-Schwefe, GH; Uberall, MA | 1 |
| Dankiewicz, EH; Haddox, JD | 1 |
| Lynch, SY; Miller, K; Munera, C; Pergolizzi, JV; Raffa, R; Ripa, SR; Wen, W; Yarlas, A | 1 |
| Akehurst, R; Dunlop, W; Hirst, A; Hirst, M; Knight, C | 1 |
| Barnett, CJ; Bergese, SD; Kamar, N; Kitzmiller, JP; Luzum, JA; Mikulik, E; Steiner, NS; Stoicea, N | 1 |
| Andresen, T; Dahan, A; Drewes, AM; Graversen, C; Olesen, AE; Olofsen, E | 1 |
| Cipriano, A; Harris, SC; Munera, C; Wang, Y | 1 |
| Díaz-Jaime, FC; García-Morales, N; Garrigues, V; Herreras-López, J; Ortiz, V; Ortuño, J; Sáez-González, E | 1 |
| Cuevas-Trisan, R; DiScala, S; Melendez-Benabe, J; Nazario, M; Onofrio, S; Vartan, CM | 1 |
| Coplan, PM; Harikrishnan, V; Perkel, C; Sessler, NE; Singh, R | 1 |
| Cai, W; Fan, J; Tang, J; Yao, Y; Yin, G; Zhou, W | 1 |
| Ahn, HS; Chang, BS; Kim, HJ; Lee, CK; Nam, Y; Yeom, JS | 1 |
| Bin, SI; Chan, SK; Chung, CK; In, Y; Kim, H; Lichauco, JJ; Mok, CC; Moon, H; Moon, YW; Ng, TK; Penserga, EG; Shin, DA; Yoon, DH; You, D | 1 |
| Bjorvatn, B; Blytt, KM; Flo, E; Husebo, B | 1 |
| Dahm, P; Norrlid, H; Tennvall, GR | 1 |
| Behm, B; Davis, MP; Pasternak, G | 1 |
| Abad-Santos, F; Álvarez, C; García-Arieta, A; González-Rojano, E; Gordon, J; Marcotegui, J; Morales-Alcelay, S | 1 |
| Dhawan, A; Modak, T; Sarkar, S | 1 |
| Buckley, NA; Litchfield, M; Narayan, SW; Pearson, SA; Schaffer, AL; Zheng, D; Zoega, H | 1 |
| Blanco-Antona, F; García-Cenador, B; González-Sarmiento, R; Lozano, FS | 1 |
| Londhe, S; Oak, M; Patwardhan, M; Shah, R | 1 |
| Lee, F; Saal, D | 1 |
| Li, FD; Li, WM; Sun, LC; Xu, H | 1 |
| Carter, EB; Galati, BM; Kelly, JC; Nazeer, S; Perez, M; Raghuraman, N; Russell, S | 1 |
| Hakomäki, H; Kokki, H; Kokki, M; Lehtonen, M; Ranta, VP; Räsänen, J; Voipio, HM | 1 |
| Fudin, J; Mendoza, K; Meyer-Junco, L; Rea, B | 1 |
| Hammell, DC; Hassan, HE; Stinchcomb, AL; Thomas, S | 1 |
| Hakomäki, H; Härkänen, L; Huopio, J; Kokki, H; Kokki, M; Korhonen, S; Lehtonen, M; Sjövall, S | 1 |
8 review(s) available for oxybutynin and buprenorphine
| Article | Year |
|---|---|
Buprenorphine 5, 10 and 20 μg/h transdermal patch: a review of its use in the management of chronic non-malignant pain.
Topics: Analgesics, Opioid; Buprenorphine; Chronic Disease; Dose-Response Relationship, Drug; Humans; Pain; Pain Measurement; Randomized Controlled Trials as Topic; Time Factors; Transdermal Patch; Treatment Outcome | 2011 |
Buprenorphine 5, 10 and 20 μg/h transdermal patch: a guide to its use in chronic non-malignant pain.
Topics: Analgesics, Opioid; Buprenorphine; Chronic Pain; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Labeling; European Union; Humans; Transdermal Patch | 2012 |
Systematic review of efficacy and safety of buprenorphine versus fentanyl or morphine in patients with chronic moderate to severe pain.
Topics: Administration, Oral; Analgesics, Opioid; Buprenorphine; Chronic Pain; Constipation; Fentanyl; Humans; Morphine; Nausea; Pain; Pain Measurement; Transdermal Patch; Treatment Outcome | 2012 |
The transdermal delivery of fentanyl.
Topics: Administration, Cutaneous; Analgesics; Analgesics, Opioid; Buprenorphine; Clinical Trials as Topic; Drug Delivery Systems; Drug Industry; Fentanyl; Humans; Pain; Pharmaceutical Preparations; Skin; Temperature; Time Factors; Transdermal Patch | 2013 |
Buprenorphine: revisiting the efficacy of transdermal delivery system.
Topics: Analgesics, Opioid; Buprenorphine; Chronic Pain; Drug Delivery Systems; Humans; Transdermal Patch | 2015 |
Treating Chronic Pain: An Overview of Clinical Studies Centered on the Buprenorphine Option.
Topics: Administration, Sublingual; Analgesics, Opioid; Animals; Buprenorphine; Chemistry, Pharmaceutical; Chronic Pain; Dose-Response Relationship, Drug; Drug Therapy, Combination; Drug Tolerance; Humans; Narcotic Antagonists; Observational Studies as Topic; Randomized Controlled Trials as Topic; Receptors, Opioid; Substance-Related Disorders; Systematic Reviews as Topic; Transdermal Patch | 2018 |
Sex-by-formulation interaction in bioequivalence trials with transdermal patches.
Topics: Analgesics, Opioid; Buprenorphine; Cholinesterase Inhibitors; Female; Fentanyl; Humans; Male; Rivastigmine; Sex Characteristics; Therapeutic Equivalency; Transdermal Patch | 2019 |
Transdermal buprenorphine patch: Potential for role in management of opioid dependence.
Topics: Buprenorphine; Humans; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders; Secondary Prevention; Transdermal Patch | 2019 |
19 trial(s) available for oxybutynin and buprenorphine
| Article | Year |
|---|---|
Pharmacokinetic/pharmacodynamic relationships of transdermal buprenorphine and fentanyl in experimental human pain models.
Topics: Adult; Analgesics, Opioid; Buprenorphine; Capsaicin; Cold Temperature; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Fentanyl; Hot Temperature; Humans; Hyperalgesia; Male; Models, Biological; Pain; Pain Measurement; Time Factors; Transdermal Patch; Young Adult | 2011 |
Efficacy and safety of buprenorphine transdermal system (BTDS) for chronic moderate to severe low back pain: a randomized, double-blind study.
Topics: Administration, Cutaneous; Analgesics, Opioid; Buprenorphine; Chronic Pain; Double-Blind Method; Female; Humans; Low Back Pain; Male; Middle Aged; Oxycodone; Transdermal Patch; Treatment Outcome | 2011 |
Transdermal buprenorphine in the treatment of cancer and non-cancer pain - the results of multicenter studies in Poland.
Topics: Analgesics, Opioid; Buprenorphine; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasms; Pain; Poland; Prospective Studies; Severity of Illness Index; Transdermal Patch | 2011 |
A randomized, 14-day, double-blind study evaluating conversion from hydrocodone/acetaminophen (Vicodin) to buprenorphine transdermal system 10 μg/h or 20 μg/h in patients with osteoarthritis pain.
Topics: Acetaminophen; Administration, Cutaneous; Administration, Oral; Aged; Analgesics, Opioid; Anti-Inflammatory Agents, Non-Steroidal; Arthralgia; Buprenorphine; Double-Blind Method; Drug Combinations; Drug Substitution; Female; Humans; Hydrocodone; Kaplan-Meier Estimate; Male; Middle Aged; Osteoarthritis; Pain Measurement; Time Factors; Transdermal Patch; Treatment Outcome; United States | 2012 |
Pharmacokinetics of transdermal buprenorphine patch in the elderly.
Topics: Administration, Cutaneous; Aged; Aged, 80 and over; Aging; Analgesics, Opioid; Area Under Curve; Buprenorphine; Female; Humans; Male; Middle Aged; Transdermal Patch | 2013 |
A feasibility study of transdermal buprenorphine versus transdermal fentanyl in the long-term management of persistent non-cancer pain.
Topics: Administration, Cutaneous; Adult; Analgesics, Opioid; Buprenorphine; Chronic Disease; Chronic Pain; Feasibility Studies; Female; Fentanyl; Humans; Longitudinal Studies; Male; Neoplasms; Pain Measurement; Prospective Studies; Transdermal Patch; Treatment Outcome | 2013 |
Buprenorphine transdermal system and quality of life in opioid-experienced patients with chronic low back pain.
Topics: Administration, Cutaneous; Adult; Analgesics, Opioid; Buprenorphine; Chronic Pain; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Low Back Pain; Male; Middle Aged; Quality of Life; Severity of Illness Index; Transdermal Patch; Treatment Outcome | 2013 |
A novel approach to pharmaco-EEG for investigating analgesics: assessment of spectral indices in single-sweep evoked brain potentials.
Topics: Adult; Analgesics, Opioid; Brain; Buprenorphine; Cross-Over Studies; Data Interpretation, Statistical; Double-Blind Method; Electric Stimulation; Electroencephalography; Evoked Potentials; Fentanyl; Healthy Volunteers; Humans; Male; Pain; Pain Measurement; Transdermal Patch; Young Adult | 2013 |
The response of agitated behavior to pain management in persons with dementia.
Topics: Acetaminophen; Aged, 80 and over; Analgesics; Buprenorphine; Delayed-Action Preparations; Dementia; Female; gamma-Aminobutyric Acid; Humans; Male; Morphine; Norway; Nursing Homes; Pain; Pain Management; Pregabalin; Psychomotor Agitation; Transdermal Patch | 2014 |
Impact of a stepwise protocol for treating pain on pain intensity in nursing home patients with dementia: a cluster randomized trial.
Topics: Acetaminophen; Activities of Daily Living; Aged; Aged, 80 and over; Analgesics; Buprenorphine; Clinical Protocols; Dementia; Female; gamma-Aminobutyric Acid; Humans; Male; Morphine; Norway; Nursing Homes; Pain; Pain Management; Pain Measurement; Pregabalin; Transdermal Patch; Treatment Outcome | 2014 |
Buprenorphine transdermal system compared with placebo reduces interference in functioning for chronic low back pain.
Topics: Administration, Cutaneous; Adult; Analgesics, Opioid; Buprenorphine; Chronic Pain; Double-Blind Method; Female; Humans; Low Back Pain; Male; Middle Aged; Pain Measurement; Transdermal Patch; Treatment Outcome | 2015 |
Stochastic Pharmacokinetic-Pharmacodynamic Analysis of the Effect of Transdermal Buprenorphine on Electroencephalogram and Analgesia.
Topics: Adult; Analgesia; Buprenorphine; Cross-Over Studies; Double-Blind Method; Electroencephalography; Humans; Male; Stochastic Processes; Transdermal Patch; Treatment Outcome; Young Adult | 2015 |
Dose-Dependent Flux of Buprenorphine Following Transdermal Administration in Healthy Subjects.
Topics: Administration, Cutaneous; Adult; Analgesics, Opioid; Biotransformation; Buprenorphine; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Female; Healthy Volunteers; Humans; Male; Transdermal Patch; Young Adult | 2016 |
Application of a buprenorphine transdermal patch for the perioperative analgesia in patients who underwent simple lumbar discectomy.
Topics: Administration, Cutaneous; Administration, Intravenous; Administration, Oral; Analgesics, Opioid; Buprenorphine; Celecoxib; Cyclooxygenase 2 Inhibitors; Diskectomy; Female; Humans; Isoxazoles; Lumbar Vertebrae; Male; Middle Aged; Pain Measurement; Pain, Postoperative; Patient Satisfaction; Perioperative Care; Tramadol; Transdermal Patch; Treatment Outcome | 2017 |
Comparative study of the efficacy of transdermal buprenorphine patches and prolonged-release tramadol tablets for postoperative pain control after spinal fusion surgery: a prospective, randomized controlled non-inferiority trial.
Topics: Buprenorphine; Humans; Pain Measurement; Pain, Postoperative; Prospective Studies; Spinal Fusion; Tablets; Tramadol; Transdermal Patch; Treatment Outcome | 2017 |
Effectiveness and tolerability of transdermal buprenorphine patches: a multicenter, prospective, open-label study in Asian patients with moderate to severe chronic musculoskeletal pain.
Topics: Administration, Cutaneous; Adult; Aged; Analgesics, Opioid; Buprenorphine; Chronic Pain; Female; Hong Kong; Humans; Male; Middle Aged; Musculoskeletal Pain; Pain Management; Pain Measurement; Philippines; Prospective Studies; Quality of Life; Republic of Korea; Surveys and Questionnaires; Transdermal Patch; Treatment Outcome | 2017 |
Effects of pain treatment on sleep in nursing home patients with dementia and depression: A multicenter placebo-controlled randomized clinical trial.
Topics: Acetaminophen; Adult; Aged; Analgesics; Buprenorphine; Dementia; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Middle Aged; Norway; Nursing Homes; Pain; Pain Management; Pain Measurement; Sleep Wake Disorders; Transdermal Patch | 2018 |
Efficacy and Safety of Buprenorphine Transdermal Patch for Immediate Postoperative Analgesia After Total Knee Arthroplasty Surgery.
Topics: Aged; Analgesics, Opioid; Anesthetics, Local; Arthroplasty, Replacement, Knee; Buprenorphine; Humans; Middle Aged; Pain Measurement; Pain, Postoperative; Prospective Studies; Transdermal Patch | 2020 |
Analgesic impact of buprenorphine transdermal patch in total hip arthroplasty: A randomized controlled trial protocol.
Topics: Acetaminophen; Administration, Intravenous; Administration, Oral; Analgesics, Non-Narcotic; Analgesics, Opioid; Arthroplasty, Replacement, Hip; Buprenorphine; Case-Control Studies; Double-Blind Method; Female; Humans; Length of Stay; Male; Pain Measurement; Pain, Postoperative; Patient Satisfaction; Postoperative Complications; Prospective Studies; Tramadol; Transdermal Patch | 2020 |
26 other study(ies) available for oxybutynin and buprenorphine
| Article | Year |
|---|---|
Rifampin reduces oral morphine absorption: a case of transdermal buprenorphine selection based on morphine pharmacokinetics.
Topics: Administration, Oral; Analgesics, Opioid; Antibiotics, Antitubercular; ATP Binding Cassette Transporter, Subfamily B, Member 1; Buprenorphine; Drug Interactions; Hospitals, Veterans; Humans; Male; Middle Aged; Morphine; Rifampin; Transdermal Patch | 2012 |
Application site adverse events associated with the buprenorphine transdermal system: a pooled analysis.
Topics: Administration, Cutaneous; Aged; Buprenorphine; Chronic Pain; Clinical Trials, Phase III as Topic; Dermatitis, Allergic Contact; Double-Blind Method; Female; Humans; Male; Middle Aged; Transdermal Patch | 2013 |
Safety and efficacy of transdermal buprenorphine and transdermal fentanyl in the treatment of neuropathic pain in AIDS patients.
Topics: Acquired Immunodeficiency Syndrome; Adult; Analgesics, Opioid; Buprenorphine; CD4-CD8 Ratio; Female; Fentanyl; Humans; Karnofsky Performance Status; Male; Middle Aged; Neuralgia; Pain Measurement; Patient Satisfaction; Transdermal Patch; Treatment Outcome | 2013 |
Dose patterns among patients using low-dose buprenorphine patches.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Analgesics, Opioid; Buprenorphine; Dose-Response Relationship, Drug; Drug Tolerance; Female; Humans; Male; Middle Aged; Opioid-Related Disorders; Transdermal Patch; Young Adult | 2013 |
[Buprenorphine transdermal patch (Norspan tape)].
Topics: Analgesics, Opioid; Buprenorphine; Chronic Pain; Humans; Pain, Intractable; Transdermal Patch | 2013 |
A case of topical opioid-induced delirium mistaken as behavioural and psychological symptoms of dementia in demented state.
Topics: Aged, 80 and over; Analgesics, Opioid; Buprenorphine; Confusion; Delirium; Dementia; Female; Hallucinations; Humans; Japan; Low Back Pain; Transdermal Patch; Treatment Outcome | 2013 |
Buprenorphine for chronic pain.
Topics: Analgesics, Opioid; Buprenorphine; Chronic Pain; Humans; Opiate Substitution Treatment; Opioid-Related Disorders; Transdermal Patch | 2013 |
Is buprenorphine transdermal patch equally safe and effective in younger and elderly patients with osteoarthritis-related pain? Results of an age-group controlled study.
Topics: Age Factors; Aged; Aged, 80 and over; Analgesics, Opioid; Buprenorphine; Chronic Pain; Female; Humans; Male; Middle Aged; Osteoarthritis; Outcome Assessment, Health Care; Pain Measurement; Prospective Studies; Sleep; Transdermal Patch | 2014 |
Predicting medication persistence to buprenorphine transdermal system.
Topics: Administration, Cutaneous; Adult; Aged; Analgesics, Non-Narcotic; Analgesics, Opioid; Anti-Inflammatory Agents, Non-Steroidal; Buprenorphine; Chronic Pain; Databases, Factual; Drug Therapy, Combination; Female; Humans; Male; Medication Adherence; Middle Aged; Pain Measurement; Time Factors; Transdermal Patch | 2015 |
US practitioner prescribing practices and patient characteristics of those newly treated with a buprenorphine transdermal patch system.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Analgesics, Opioid; Buprenorphine; Chronic Pain; Databases, Factual; Female; Guideline Adherence; Humans; Male; Middle Aged; Practice Guidelines as Topic; Practice Patterns, Physicians'; Retrospective Studies; Transdermal Patch; United States; Young Adult | 2014 |
Medication errors related to transdermal opioid patches: lessons from a regional incident reporting system.
Topics: Adverse Drug Reaction Reporting Systems; Analgesics, Opioid; Buprenorphine; Fentanyl; Humans; Medication Errors; Pain; Transdermal Patch | 2014 |
[Long-term treatment of chronic pain with low-dose 7-day buprenorphine transdermal patch. Observational data from elderly patients of pain relief and quality of life].
Topics: Activities of Daily Living; Aged; Aged, 80 and over; Anxiety; Buprenorphine; Chronic Pain; Depression; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Pain Measurement; Quality of Life; Transdermal Patch | 2013 |
Clarification on transdermal buprenorphine.
Topics: Analgesics, Opioid; Buprenorphine; Chronic Pain; Humans; Transdermal Patch | 2014 |
Tramadol and the risk of fracture in an elderly female population: a cost utility assessment with comparison to transdermal buprenorphine.
Topics: Aged; Aged, 80 and over; Buprenorphine; Chronic Pain; Cost-Benefit Analysis; Drug Costs; Female; Fractures, Bone; Health Care Costs; Humans; Models, Economic; Quality-Adjusted Life Years; Risk Factors; Tramadol; Transdermal Patch; United Kingdom | 2016 |
Opioid-induced functional esophagogastric junction obstruction.
Topics: Analgesics, Opioid; Buprenorphine; Deglutition Disorders; Esophageal Spasm, Diffuse; Esophageal Sphincter, Lower; Female; Humans; Low Back Pain; Manometry; Middle Aged; Transdermal Patch | 2017 |
The Use of Transdermal Buprenorphine in Complex Regional Pain Syndrome: A Report of Two Cases.
Topics: Aged; Analgesics, Opioid; Buprenorphine; Complex Regional Pain Syndromes; Humans; Male; Pain Measurement; Transdermal Patch; Treatment Outcome | 2016 |
Comparison of abuse, suspected suicidal intent, and fatalities related to the 7-day buprenorphine transdermal patch versus other opioid analgesics in the National Poison Data System.
Topics: Adult; Aged; Aged, 80 and over; Analgesics, Opioid; Buprenorphine; Cause of Death; Chronic Pain; Cohort Studies; Female; Humans; Male; Middle Aged; Poison Control Centers; Prescription Drug Misuse; Retrospective Studies; Sex Factors; Suicide; Transdermal Patch; United States | 2017 |
Evaluation of the cost-effectiveness of buprenorphine in treatment of chronic pain using competing EQ-5D weights.
Topics: Aged; Aged, 80 and over; Analgesics, Opioid; Buprenorphine; Chronic Pain; Clinical Trials as Topic; Cost-Benefit Analysis; Female; Health Care Costs; Humans; Male; Middle Aged; Pain Measurement; Patient Outcome Assessment; Quality of Life; Quality-Adjusted Life Years; Sweden; Transdermal Patch; Treatment Outcome | 2015 |
Anticipating the effects of restricting high-dose preparations of strong opioids in Australia: A population-based analysis to inform the current policy debate.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Analgesics, Opioid; Australia; Buprenorphine; Child; Child, Preschool; Dose-Response Relationship, Drug; Drug Prescriptions; Female; Humans; Infant; Infant, Newborn; Male; Middle Aged; Opioid Epidemic; Opioid-Related Disorders; Oxycodone; Pain; Policy Making; Practice Patterns, Physicians'; Sex Factors; Transdermal Patch; Young Adult | 2019 |
Transdermal Buprenorphine for Controlling Pain in Patients with Critical Lower-Limb Ischemia.
Topics: Administration, Cutaneous; Analgesics, Opioid; Buprenorphine; Humans; Ischemia; Pain; Pain Management; Transdermal Patch | 2020 |
Rapid Induction Therapy for Opioid-Use Disorder Using Buprenorphine Transdermal Patch: A Case Series.
Topics: Adult; Aged; Analgesics, Opioid; Buprenorphine; Buprenorphine, Naloxone Drug Combination; Female; Humans; Male; Middle Aged; Opiate Substitution Treatment; Opioid-Related Disorders; Transdermal Patch | 2020 |
Buprenorphine Patch as a Bridge to Sublingual Treatment of Opioid Use Disorder in Pregnancy.
Topics: Administration, Sublingual; Adult; Buprenorphine; Female; Humans; Narcotic Antagonists; Opioid-Related Disorders; Pregnancy; Pregnancy Complications; Prenatal Care; Transdermal Patch; Young Adult | 2021 |
MATERNAL AND FETAL BUPRENORPHINE PHARMACOKINETICS IN PREGNANT SHEEP DURING TRANSDERMAL PATCH DOSING: Buprenorphine pharmacokinetics in pregnant sheep.
Topics: Analgesics, Opioid; Animals; Buprenorphine; Female; Fetus; Humans; Opiate Substitution Treatment; Pregnancy; Sheep; Transdermal Patch | 2021 |
Application Site Reactions from the Buprenorphine Transdermal Patch: A Case Series.
Topics: Administration, Cutaneous; Analgesics, Opioid; Buprenorphine; Chronic Pain; Humans; Transdermal Patch | 2022 |
In Vitro-In Vivo Correlation of Buprenorphine Transdermal Systems Under Normal and Elevated Skin Temperature.
Topics: Administration, Cutaneous; Buprenorphine; Drug Delivery Systems; Humans; Permeability; Skin; Skin Absorption; Skin Temperature; Transdermal Patch | 2023 |
Buprenorphine plasma and cerebrospinal fluid concentrations in osteoarthritis patients during low-dose transdermal patch dosing.
Topics: Administration, Cutaneous; Analgesics, Opioid; Buprenorphine; Humans; Osteoarthritis; Transdermal Patch | 2023 |